The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Huntsman's first-quarter results demonstrated sequential volume improvements and margin expansion, suggesting the company has reached a cyclical bottom. Similarly, Eastman Chemical reported a 5% year-over-year decrease in Q1 revenue to $2.177 billion, with adjusted EPS falling to $1.09 from $1.91. However, Eastman projects a strong Q2 rebound, issuing adjusted EPS guidance between $1.70 and $1.90. Global supply tightening and logistics disruptions are contributing to sequential performance gains across the sector. Management cost-cutting initiatives at both firms are beginning to yield early benefits, reinforcing a more optimistic outlook for the coming quarters. Both companies remain focused on operational efficiency as end markets show early signs of a gradual recovery.
Sign in to access this content
Sign In